Janus Henderson Group PLC Has $5.64 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Janus Henderson Group PLC lifted its position in Kenvue Inc. (NYSE:KVUE) by 20.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 263,969 shares of the company’s stock after buying an additional 44,393 shares during the quarter. Janus Henderson Group PLC’s holdings in Kenvue were worth $5,640,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of KVUE. Price T Rowe Associates Inc. MD raised its holdings in Kenvue by 3.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company’s stock worth $5,249,665,000 after acquiring an additional 8,211,748 shares during the period. Vanguard Group Inc. boosted its holdings in Kenvue by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company’s stock valued at $4,665,908,000 after acquiring an additional 1,636,741 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Kenvue by 12.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company’s stock valued at $2,085,070,000 after purchasing an additional 10,682,003 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Kenvue by 3.1% in the fourth quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company’s stock worth $980,989,000 after purchasing an additional 1,391,854 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Kenvue by 61.5% during the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company’s stock worth $912,059,000 after purchasing an additional 16,269,721 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

KVUE has been the subject of several recent analyst reports. Evercore ISI began coverage on Kenvue in a research note on Monday, March 24th. They set an “in-line” rating and a $25.00 target price for the company. Barclays increased their price objective on Kenvue from $22.00 to $23.00 and gave the company an “equal weight” rating in a research report on Monday, May 12th. Piper Sandler boosted their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, February 24th. Redburn Atlantic initiated coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a “neutral” rating and a $23.50 target price for the company. Finally, Citigroup raised their price target on shares of Kenvue from $22.00 to $24.50 and gave the stock a “neutral” rating in a research report on Friday, May 9th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $25.33.

Kenvue Trading Up 1.1%

Shares of Kenvue stock opened at $24.15 on Monday. The firm has a market capitalization of $46.34 billion, a PE ratio of 45.57, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company’s fifty day moving average price is $23.16 and its two-hundred day moving average price is $22.59. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm’s revenue for the quarter was down 3.9% compared to the same quarter last year. During the same period last year, the firm earned $0.28 EPS. On average, analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be issued a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date is Wednesday, May 14th. Kenvue’s payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.